0001878646-23-000027.txt : 20230907 0001878646-23-000027.hdr.sgml : 20230907 20230907142638 ACCESSION NUMBER: 0001878646-23-000027 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230907 DATE AS OF CHANGE: 20230907 EFFECTIVENESS DATE: 20230907 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Zena Therapeutics Inc. CENTRAL INDEX KEY: 0001992540 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-491564 FILM NUMBER: 231241919 BUSINESS ADDRESS: STREET 1: 155 VILLAGE BLVD STREET 2: SUITE 130 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 848-229-4215 MAIL ADDRESS: STREET 1: 155 VILLAGE BLVD STREET 2: SUITE 130 CITY: PRINCETON STATE: NJ ZIP: 08540 D 1 primary_doc.xml X0708 D LIVE 0001992540 Zena Therapeutics Inc. 155 VILLAGE BLVD SUITE 130 PRINCETON NJ NEW JERSEY 08540 848-229-4215 DELAWARE None None Corporation true 2021 Eileen Carry c/o Issuer, 155 Village Blvd. Suite 130 Princeton NJ NEW JERSEY 08540 Executive Officer Director Ariane Vasilatis c/o Issuer, 155 Village Blvd. Suite 130 Princeton NJ NEW JERSEY 08540 Executive Officer Director Pharmaceuticals Decline to Disclose 06b false 2023-08-11 false true false 0 500000 500000 0 false 1 0 0 0 false Zena Therapeutics Inc. /s/Eileen Carry, Ph.D. Eileen Carry Chief Scientific Officer 2023-09-07